NCT01382953

Brief Summary

The purpose of this research is to simplify the standard recording system of the heart rhythm. The investigators desire to improve the ease of monitoring the cardiac rhythm for 24 hours. The investigators intent is to use a very small, innovative monitoring patch system that relieves the patient of wearing a cumbersome and uncomfortable recording system. This research trial will carry the title "The Simple ECG Monitoring" for Comparison of a Sternal ECG Recording System with a Standard ECG Recording System for Holter Monitoring. The data from the investigational device is for comparative purposes only. It will not be used by medical personnel for study subject treatment or diagnostic purposes.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2011

Shorter than P25 for all trials

Geographic Reach
2 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 27, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2011

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

January 10, 2012

Status Verified

January 1, 2012

Enrollment Period

2 months

First QC Date

June 24, 2011

Last Update Submit

January 7, 2012

Conditions

Keywords

Holter Monitor, Ambulatory Electrocardiography Monitoring

Outcome Measures

Primary Outcomes (1)

  • To compare the *diagnostic yield and *ECG signal quality of the standard Holter with that of the Simple ECG Monitoring patch

    * Diagnostic yield is the proportion of patients for whom an arrhythmogenic source of symptoms is established, or ruled out. The two systems will be correlated following completion of blinded batch reviews. * ECG signal quality is scoring the ability of each system to record electrical activity from the atrium (P-waves)using the following scale: Excellent, Good, Fair, Poor, Non-existent.

    24 Hours

Secondary Outcomes (4)

  • Skin comfort or discomfort: Was skin irritated?

    48 Hours

  • Device comfort

    48 Hours

  • Device stability and contact

    48 Hours

  • User interface

    48 Hours

Interventions

The standard Holter and Investigational patch will be worn simultaneously for 24 hours. A single follow-up visit will follow in 2 days to remove both systems which will be sent away for analysis with the results of the standard system used, if pertinent, for patient management.

Also known as: Cardiac Science Burdick Holter., Investigational patch trilobite system.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary Care Clinic referral, Cardiology Clinic, Electrophysiology Clinic

You may qualify if:

  • Syncope of uncertain etiology or
  • Pre-syncope of uncertain etiology or
  • Palpitations of uncertain etiology or
  • Management of known AF/SVT patients

You may not qualify if:

  • Any abnormal or friable skin over the anterior thorax and upper abdomen
  • Sternal incision within 3 months from the date of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of Chicago

Chicago, Illinois, 60637, United States

Location

Gene Trobaugh Cardiology

Enumclaw, Washington, 98022, United States

Location

Auckland City Hospital

Auckland, 1001, New Zealand

Location

Christchurch Hospital

Christchurch, 4710, New Zealand

Location

MeSH Terms

Conditions

SyncopeAtrial FibrillationTachycardia, Supraventricular

Condition Hierarchy (Ancestors)

UnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesTachycardiaCardiac Conduction System Disease

Study Officials

  • Gust H. Bardy, MD

    Seattle Institute for Cardiac Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2011

First Posted

June 27, 2011

Study Start

August 1, 2011

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

January 10, 2012

Record last verified: 2012-01

Locations